STARPharmaceuticals
Strides Pharma Science Ltd — PE Ratio & Valuation Analysis
₹937.75
+1.19%
Current P/E19.35xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E2.3x741.3% above avg
✅
39.1% Discount to Industry
STAR P/E 19.35x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹390.50 | ₹900 | 2.3x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Strides Pharma Science Ltd Valuation
Strides Pharma Science Ltd (STAR) currently trades at 19.35x earnings. The Pharmaceuticals sector average PE is 31.77x. STAR is trading at a discount to peers — may indicate relative value. Historically, STAR has traded at an average PE of 2.3x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
150.67%
Dividend Yield
0.44%
More on Strides Pharma Science Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.